Filtered By:
Source: International Journal of Cardiology
Condition: Atrial Fibrillation
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 388 results found since Jan 2013.
Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: A national wide database analysis
Abstract: Background: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism in patients with atrial fibrillation (AF) are largely derived from western cohorts. The purpose of the present study is to assess the potential risk factors for stroke and major adverse cardiac events (MACE) in a large population of Chinese AF patients presenting to emergency department.Methods: The Chinese AF registry is a multicenter, prospective, observational study with 1year follow up. Patients who presented to an emergency department with atrial fibrillation or atrial flutter were recruited from November...
Source: International Journal of Cardiology - March 17, 2014 Category: Cardiology Authors: Yan-min Yang, Xing-hui Shao, Jun Zhu, Han Zhang, Yao Liu, Xin Gao, Li-sheng Liu, Li-tian Yu, Li Zhao, Peng-fei Yu, Hua Zhang, Qing He, Xiao-dan Gu Tags: Original Articles Source Type: research
Statin treatment is associated with improved prognosis in patients with AF-related stroke
The most recent ACC/AHA guidelines recommend high-intensity statin therapy in ischemic stroke patients of presumably atherosclerotic origin. On the contrary, there is no specific recommendation for the use of statin in patients with non-atherosclerotic stroke, e.g. strokes related to atrial fibrillation (AF). We investigated whether statin treatment in patients with AF-related stroke is associated with improved survival and reduced risk for stroke recurrence and future cardiovascular events.
Source: International Journal of Cardiology - September 25, 2014 Category: Cardiology Authors: G. Ntaios, V. Papavasileiou, K. Makaritsis, H. Milionis, E. Manios, P. Michel, G.Y.H. Lip, K. Vemmos Source Type: research
Antithrombotic therapy for atrial fibrillation in patients with acute ischemic stroke or transient ischemic attack
Although warfarin is more effective than are antiplatelet drugs for preventing stroke in patients with atrial fibrillation (AF), it is usually underutilized after stroke for various reasons. A global AF registry study indicated that warfarin was prescribed even less frequently for stroke prevention in Asia than in the West [1]. The major problem of using warfarin in Asian populations is the increased risk of intracranial bleeding. The purpose of this study was to evaluate the use of antithrombotic therapy at discharge in a consecutive cohort of patients with acute ischemic stroke or transient ischemic attack (TIA) and AF.
Source: International Journal of Cardiology - November 13, 2014 Category: Cardiology Authors: Poh-Shiow Yeh, Chun-Ming Yang, Sheng-Hsiang Lin, Wei-Ming Wang, Po-Sheng Chen, Huey-Juan Lin, Kao-Chang Lin, Chia-Yu Chang, Tain-Junn Cheng, Yi-Heng Li Tags: Letter to the editor Source Type: research
Characteristics and outcomes of ischemic stroke in patients with known atrial fibrillation or atrial fibrillation diagnosed after stroke
It is unclear whether ischemic stroke patients with known atrial fibrillation (KAF) had different outcomes than those with atrial fibrillation diagnosed after stroke (AFDAS). We aimed to explore the characteristics and outcomes in ischemic stroke patients with KAF or AFDAS.
Source: International Journal of Cardiology - April 13, 2018 Category: Cardiology Authors: Cheng-Yang Hsieh, Cheng-Han Lee, Darren Philbert Wu, Sheng-Feng Sung Source Type: research
The real world of stroke incidence in patients with hypertrophic cardiomyopathy
We have read a paper with great interest written by Fumagalli and colleagues concerning “the incidence of stroke in patients with hypertrophic cardiomyopathy (HCM) among different heart rhythm” [1]. In this paper, the authors found that stroke rates in HCM patients no prior history of atrial fibrillation (AF), stroke rates were similar in those with de novo AF or stable sinus rate (SR). And they further observed that severe left atrium dilatation was a powerful risk factor, irrespective of AF. The results provided evidence for the anticoagulation strategies to prevent stroke in patients with HCM.
Source: International Journal of Cardiology - July 7, 2023 Category: Cardiology Authors: Xinru Chen Tags: Letter to the Editor Source Type: research
Low stroke risk after elective cardioversion of atrial fibrillation: An analysis of the Flec-SL trial
Conclusion: Strokes are rare in this large, prospectively followed cohort of patients undergoing cardioversion for AF and receiving antithrombotic therapy following local routine. These results support adherence to current recommendations for anticoagulation during cardioversion of AF.
Source: International Journal of Cardiology - July 22, 2013 Category: Cardiology Authors: Stavros Apostolakis, Karl Georg Haeusler, Michael Oeff, Andras Treszl, Dietrich Andresen, Martin Borggrefe, Gregory Y.H. Lip, Thomas Meinertz, Ulrich Parade, Alexander Samol, Gerhard Steinbeck, Karl Wegscheider, Günter Breithardt, Paulus Kirchhof Tags: Original Articles Source Type: research
Non-Vitamin K Oral Anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) have changed the landscape for stroke prevention in atrial fibrillation (AF). Given the huge burden of AF in Asians, more attention to stroke prevention is clearly needed. Aiming to provide an overview and reappraisal of stroke prevention in Asians with AF, we searched MEDLINE for information on NOACs in Asians. In addition, abstracts from national and international cardiovascular meetings were studied to identify unpublished studies.In the 4 recent Phase 3 trials comparing NOACs to warfarin, a consistent pattern is evident.
Source: International Journal of Cardiology - November 26, 2014 Category: Cardiology Authors: Gregory Y.H. Lip, Kang-Ling Wang, Chern-En Chiang Tags: Review Source Type: research
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
Non-vitamin K antagonist oral anticoagulants (NOACs) have changed the landscape for stroke prevention in atrial fibrillation (AF). Given the huge burden of AF in Asians, more attention to stroke prevention is clearly needed. Aiming to provide an overview and reappraisal of stroke prevention in Asians with AF, we searched MEDLINE for information on NOACs in Asians. In addition, abstracts from national and international cardiovascular meetings were studied to identify unpublished studies.In the 4 recent Phase 3 trials comparing NOACs to warfarin, a consistent pattern is evident.
Source: International Journal of Cardiology - November 26, 2014 Category: Cardiology Authors: Gregory Y.H. Lip, Kang-Ling Wang, Chern-En Chiang Tags: Review Source Type: research
Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda
Atrial fibrillation (AF) is the most common heart arrhythmia. Untreated AF incurs a considerable burden of stroke and associated healthcare costs. Asians have AF risk factors similar to Caucasians and similarly increased risk of AF-related stroke; however, with a vast and rapidly aging population, Asia bears a disproportionately large disease burden. Urgent action is warranted to avert this potential health crisis. Antithrombotic therapy with oral anticoagulants is the most effective means of preventing stroke in AF and is a particular priority in Asia given the increasing disease burden.
Source: International Journal of Cardiology - March 26, 2015 Category: Cardiology Authors: Chen-Huan Chen, Mien-Cheng Chen, Harry Gibbs, Sun U. Kwon, Sidney Lo, Young Keun On, Azhari Rosman, Nijasri C. Suwanwela, Ru San Tan, Louie S. Tirador, Andreas Zirlik Tags: Review Source Type: research
The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naïve, new-onset nonvalvular atrial fibrillation
Target specific oral anticoagulants (TSOACs) are alternatives to warfarin for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). Stroke prophylaxis in NVAF does not require immediate therapeutic anticoagulation; however, delaying discharge in patients treated with warfarin to achieve a therapeutic international normalized ratio (INR) may prolong hospital length of stay (LOS) compared to use of a TSOAC. We aimed to evaluate patients hospitalized for new-onset, NVAF that were initiated on either rivaroxaban or warfarin for stroke prevention on hospital-based outcomes.
Source: International Journal of Cardiology - April 30, 2015 Category: Cardiology Authors: Caitlyn Hurley, Shurui Dai, Diana M. Sobieraj Tags: Letter to the Editor Source Type: research
Is hyperuricemia a recognizable biomarker for low risk of stroke in patients with atrial fibrillation?
We found the article on ‘The relationship between hyperuricemia and the risk of stroke in the patients with atrial fibrillation’ by Chao et al. [1] to be very interesting, in which hyperuricemia was demonstrated to be a high-risk factor for ischemia stroke in patients with atrial fibrillation. In addition, the incidence of ischemia stroke in hyperuricemia patients with CHA2DS2-VASc score of 0 was significantly higher than those without hyperuricemia, and anticoagulant drugs were recommended for atrial fibrillation patients with hyperuricemia and CHA2DS2-VASc score of 0.
Source: International Journal of Cardiology - November 5, 2015 Category: Cardiology Authors: Yufan Yang, Qiming Liu, Zhihong Wu, Xuping Li, Ce Deng, Shenghua Zhou Tags: Letter to editor Source Type: research
Embolic stroke and after-admission atrial fibrillation
Although atrial fibrillation (AF) is a leading cause of recurrent embolic stroke, secondary AF after stroke has been reported frequently. Because of the different treatment each uses, it is important to detect the exact stroke-etiology.
Source: International Journal of Cardiology - August 1, 2016 Category: Cardiology Authors: Yerim Kim, Seung-Hoon Lee Source Type: research
Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10 years after first-ever ischemic stroke
Atrial fibrillation (AF) detection in ischemic stroke patients triggers initiation of oral anticoagulant therapy (OAC). However, little is known regarding whether the persistency of AF affects long-term prognosis after ischemic stroke. We aimed to assess the impact of AF types and OAC on the outcome during a 10-year follow-up (FU) after first-ever ischemic stroke.
Source: International Journal of Cardiology - January 4, 2017 Category: Cardiology Authors: Maria A Baturova, Arne Lindgren, Jonas Carlson, Yuri V Shubik, S Bertil Olsson, Pyotr G Platonov Source Type: research
Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke
Atrial fibrillation (AF) detection in ischemic stroke patients triggers initiation of oral anticoagulant therapy (OAC). However, little is known regarding whether the persistency of AF affects long-term prognosis after ischemic stroke. We aimed to assess the impact of AF types and OAC on the outcome during a 10-year follow-up (FU) after first-ever ischemic stroke.
Source: International Journal of Cardiology - January 4, 2017 Category: Cardiology Authors: Maria A Baturova, Arne Lindgren, Jonas Carlson, Yuri V Shubik, S Bertil Olsson, Pyotr G Platonov Source Type: research
